Helping adolescents and young adults with advanced cancer manage stress and build resilience
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer
This study is testing a supportive program called PRISM for young people with advanced cancer, which includes personal sessions to help them manage stress and set goals, along with a family meeting to talk about their needs, all aimed at improving their well-being during this tough time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10895146 on NIH RePORTER |
What this research studies
This research investigates a program called PRISM, designed to help adolescents and young adults facing advanced cancer. The program consists of four one-on-one sessions that focus on teaching skills such as stress management, mindfulness, and goal-setting, followed by a family meeting to discuss the patient's needs and preferences. By enhancing their ability to cope with the challenges of cancer, the program aims to improve the overall well-being of these young patients. Participants will have the opportunity to express their hopes and concerns, which can lead to better psychosocial outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults diagnosed with advanced cancer who are seeking support in managing their stress and emotional well-being.
Not a fit: Patients with early-stage cancer or those not experiencing significant stress or psychological distress may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this research could significantly improve the mental health and quality of life for adolescents and young adults with advanced cancer.
How similar studies have performed: Previous pilot studies have shown promising results for similar interventions, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Rosenberg, Abby R — Dana-Farber Cancer Inst
- Study coordinator: Rosenberg, Abby R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.